Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fever, myalgia, and arthralgia in a patient on captopril and allopurinol.

Literature DB >> 6142365

Fever, myalgia, and arthralgia in a patient on captopril and allopurinol.

A Samanta, A C Burden.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1984 PMID： 6142365 DOI： 10.1016/s0140-6736(84)92190-1

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

8 in total

1. Safety of olmesartan in a patient with telmisartan-induced myotoxicity: a case report.

Authors: Manish J Barvaliya; Viren N Naik; Ashok C Shah; Chandrabhanu R Tripathi
Journal: Br J Clin Pharmacol Date: 2015-06 Impact factor: 4.335

Review 2. Fosinopril. Clinical pharmacokinetics and clinical potential.

Authors: H Shionoiri; M Naruse; K Minamisawa; S Ueda; H Himeno; S Hiroto; I Takasaki
Journal: Clin Pharmacokinet Date: 1997-06 Impact factor: 6.447

3. Heart disease and the risk of allopurinol-associated severe cutaneous adverse reactions: a general population-based cohort study.

Authors: Chio Yokose; Na Lu; Hui Xie; Lingyi Li; Yufei Zheng; Natalie McCormick; Sharan K Rai; J Antonio Aviña-Zubieta; Hyon K Choi
Journal: CMAJ Date: 2019-09-30 Impact factor: 8.262

Review 4. ACE inhibitors. Drug interactions of clinical significance.

Authors: C Mignat; T Unger
Journal: Drug Saf Date: 1995-05 Impact factor: 5.606

5. Prevalence of potentially severe drug-drug interactions in ambulatory patients with dyslipidaemia receiving HMG-CoA reductase inhibitor therapy.

Authors: Alexandra E Rätz Bravo; Lydia Tchambaz; Anita Krähenbühl-Melcher; Lorenzo Hess; Raymond G Schlienger; Stephan Krähenbühl
Journal: Drug Saf Date: 2005 Impact factor: 5.606

Fever, myalgia, and arthralgia in a patient on captopril and allopurinol.

1. Safety of olmesartan in a patient with telmisartan-induced myotoxicity: a case report.

Review 2. Fosinopril. Clinical pharmacokinetics and clinical potential.

3. Heart disease and the risk of allopurinol-associated severe cutaneous adverse reactions: a general population-based cohort study.

Review 4. ACE inhibitors. Drug interactions of clinical significance.

5. Prevalence of potentially severe drug-drug interactions in ambulatory patients with dyslipidaemia receiving HMG-CoA reductase inhibitor therapy.

Review 6. Pharmacokinetic drug interactions with ACE inhibitors.

7. [Drug interactions in clinical practice. A pilot project for quality assurance in prescribing].

Review 8. Angiotensin-converting enzyme inhibitors side effects--physiologic and non-physiologic considerations.